Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures

European Journal of Pharmacology

Volumn 739, Issue C, 2014, Pages 83-95

  Chakroborty, Shreaya ^a   Stutzmann, Grace E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Alzheimer's disease; Amyloid; Brain; Calcium; Clinical trials; ER; IP3R; Neurodegeneration; Neuron; Ryanodine receptor; Synaptic plasticity

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; CALCIUM CHANNEL; DONEPEZIL; GALANTAMINE; ISRADIPINE; MEMANTINE; METHYLENE BLUE; NILVADIPINE; PRESENILIN; RIVASTIGMINE; ROSIGLITAZONE; RYANODINE RECEPTOR; SEMAGACESTAT; TARENFLURBIL;

ALZHEIMER DISEASE; CALCIUM CHANNELOPATHY; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CHANNEL GATING; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TARGETING; HUMAN; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE METABOLISM; TREATMENT OUTCOME; ANIMAL; CHANNELOPATHIES; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; CALCIUM CHANNELS; CHANNELOPATHIES; HUMANS;

EID: 84922828101     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.11.012     Document Type: Review

References (236)

1. T. Adasme, P. Haeger, A.C. Paula-Lima, I. Espinoza, M.M. Casas-Alarcon, M.A. Carrasco, and C. Hidalgo Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation Proc. Natl. Acad. Sci. USA 108 2011 3029 3034
2. P.S. Aisen, S. Andrieu, C. Sampaio, M. Carrillo, Z.S. Khachaturian, B. Dubois, H.H. Feldman, R.C. Petersen, E. Siemers, R.S. Doody, S.B. Hendrix, M. Grundman, L.S. Schneider, R.J. Schindler, E. Salmon, W.Z. Potter, R.G. Thomas, D. Salmon, M. Donohue, M.M. Bednar, J. Touchon, and B. Vellas Report of the task force on designing clinical trials in early (predementia) AD Neurology 76 2011 280 286
3. 2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors Cell Calcium 47 2010 264 272
4. B. Allen, E. Ingram, M. Takao, M.J. Smith, R. Jakes, K. Virdee, H. Yoshida, M. Holzer, M. Craxton, P.C. Emson, C. Atzori, A. Migheli, R.A. Crowther, B. Ghetti, M.G. Spillantini, and M. Goedert Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein J. Neurosci.: Off. J. Soc. Neurosci. 22 2002 9340 9351
5. Alzheimer's-Association Alzheimer's disease facts and figures Alzheimer's Dementia 9 2013 2
6. T.S. Anekonda, J.F. Quinn, C. Harris, K. Frahler, T.L. Wadsworth, and R.L. Woltjer L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease Neurobiol. Dis. 41 2011 62 70
7. A. Antonell, A. Llado, J. Altirriba, T. Botta-Orfila, M. Balasa, M. Fernandez, I. Ferrer, R. Sanchez-Valle, and J.L. Molinuevo A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease Neurobiol. Aging 34 2013 1772 1778
8. E. Area-Gomez, M. Del Carmen Lara Castillo, M.D. Tambini, C. Guardia-Laguarta, A.J. de Groof, M. Madra, J. Ikenouchi, M. Umeda, T.D. Bird, S.L. Sturley, and E.A Schon Upregulated function of mitochondria-associated ER membranes in Alzheimer disease EMBO J. 31 2012 4106 4123
9. U. Armato, A. Chiarini, B. Chakravarthy, F. Chioffi, R. Pacchiana, E. Colarusso, J.F. Whitfield, and I. Dal Pra Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Abeta42 prompted by exogenous fibrillary or soluble Abeta25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease Biochim. Biophys. Acta 1832 2013 1634 1652
10. P.V. Arriagada, K. Marzloff, and B.T. Hyman Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease Neurology 42 1992 1681 1688
11. I. Arrieta-Cruz, J. Wang, C. Pavlides, and G.M. Pasinetti Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease J. Alzheimer's Dis.: JAD 21 2010 649 654
12. A.A. Asuni, A. Boutajangout, D. Quartermain, and E.M. Sigurdsson Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements J. Neurosci.: Off. J. Soc. Neurosci. 27 2007 9115 9129
13. J. Avila, M. Perez, F. Lim, A. Gomez-Ramos, F. Hernandez, and J.J. Lucas Tau in neurodegenerative diseases: tau phosphorylation and assembly Neurotoxic. Res. 6 2004 477 482
14. K.D. Baker, T.M. Edwards, and N.S. Rickard The role of intracellular calcium stores in synaptic plasticity and memory consolidation Neurosci. Biobehav. Rev. 37 2013 1211 1239
15. D. Balschun, D.P. Wolfer, F. Bertocchini, V. Barone, A. Conti, W. Zuschratter, L. Missiaen, H.P. Lipp, J.U. Frey, and V. Sorrentino Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning EMBO J. 18 1999 5264 5273
16. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, I. Lieberburg, R. Motter, M. Nguyen, F. Soriano, N. Vasquez, K. Weiss, B. Welch, P. Seubert, D. Schenk, and T. Yednock Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 2000 916 919
17. 2+ store in the plasticity of central neurons Trends Pharmacol. Sci. 27 2006 78 84
18. J.M. Baughman, F. Perocchi, H.S. Girgis, M. Plovanich, C.A. Belcher-Timme, Y. Sancak, X.R. Bao, L. Strittmatter, O. Goldberger, R.L. Bogorad, V. Koteliansky, and V.K. Mootha Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter Nature 476 2011 341 345
19. Baxter, P.R., 2013. Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease.
20. M.J. Berridge Calcium regulation of neural rhythms, memory and Alzheimer's disease J. Physiol 2013 http://dx.doi.org/10.1113/jphysiol.2013.257527, epub ahead of print
21. M.J. Berridge, M.D. Bootman, and P. Lipp Calcium - a life and death signal Nature 395 1998 645 648
22. I. Bezprozvanny Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias Neurochem. Res. 36 2011 1186 1197
23. I. Bezprozvanny, and M.P. Mattson Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease Trends Neurosci. 31 2008 454 463
24. J. Birks Cholinesterase inhibitors for Alzheimer's disease Cochrane Database Syst. Rev. 1 2006 CD005593
25. D. Boehning, R.L. Patterson, L. Sedaghat, N.O. Glebova, T. Kurosaki, and S.H. Snyder Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis Nat. Cell Biol. 5 2003 1051 1061
26. D. Boehning, R.L. Patterson, and S.H. Snyder Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate Cell Cycle (Georgetown, Tex.) 3 2004 252 254
27. A. Boutajangout, J. Ingadottir, P. Davies, and E.M. Sigurdsson Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain J. Neurochem. 118 2011 658 667
28. A. Boutajangout, D. Quartermain, and E.M. Sigurdsson Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model J. Neurosci.: Off. J. Soc. Neurosci. 30 2010 16559 16566
29. R. Bravo, J.M. Vicencio, V. Parra, R. Troncoso, J.P. Munoz, M. Bui, C. Quiroga, A.E. Rodriguez, H.E. Verdejo, J. Ferreira, M. Iglewski, M. Chiong, T. Simmen, A. Zorzano, J.A. Hill, B.A. Rothermel, G. Szabadkai, and S. Lavandero Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress J. Cell Sci. 124 2011 2143 2152
30. D.L. Brody, and D.M. Holtzman Active and passive immunotherapy for neurodegenerative disorders Ann. Rev. Neurosci. 31 2008 175 193
31. A.M. Bruno, J.Y. Huang, D.A. Bennett, R.A. Marr, M.L. Hastings, and G.E. Stutzmann Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease Neurobiol. Aging 33 2012 (1001 e1001-1006)
32. 2+ transfer to mitochondria Cell 142 2010 270 283
33. R.J. Castellani, and G. Perry Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress Arch. Med. Res. 43 2012 694 698
34. W. Chadwick, N. Mitchell, B. Martin, and S. Maudsley Therapeutic targeting of the endoplasmic reticulum in Alzheimer's disease Curr. Alzheimer Res. 9 2012 110 119
35. 2+ channel function as an early preventative strategy for Alzheimer's disease PloS One 7 2012 e52056
36. S. Chakroborty, I. Goussakov, M.B. Miller, and G.E. Stutzmann Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice J. Neurosci.: Off. J. Soc. Neurosci. 29 2009 9458 9470
37. S. Chakroborty, J. Kim, C. Schneider, C. Jacobson, J. Molgo, and G.E. Stutzmann Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice J. Neurosci.: Off. J. Soc. Neurosci. 32 2012 8341 8353
38. S. Chakroborty, and G.E. Stutzmann Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction. Science China Life Sci. 54 2011 752 762
39. C.H. Chen, W. Zhou, S. Liu, Y. Deng, F. Cai, M. Tone, Y. Tone, Y. Tong, and W. Song Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease Int. J. Neuropsychopharmacol./Off. Sci. J. Collegium Int. Neuropsychopharmacol 15 2012 77 90
40. H.S. Chen, J.W. Pellegrini, S.K. Aggarwal, S.Z. Lei, S. Warach, F.E. Jensen, and S.A. Lipton Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity J. Neurosci.: Off. J. Soc. Neurosci. 12 1992 4427 4436
41. K.H. Cheung, L. Mei, D.O. Mak, I. Hayashi, T. Iwatsubo, D.E. Kang, and J.K. Foskett Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons Sci. Signaling 3 2010 ra22
42. 2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating Neuron 58 2008 871 883
43. H.J. Cho, S.M. Jin, H.D. Youn, K. Huh, and I. Mook-Jung Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling Aging Cell 7 2008 137 147
44. S.A. Chong, I. Benilova, H. Shaban, B. De Strooper, H. Devijver, D. Moechars, W. Eberle, C. Bartic, F. Van Leuven, and G. Callewaert Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study Neurobiol. Dis. 44 2011 284 291
45. R.A. Christensen, A. Shtifman, P.D. Allen, J.R. Lopez, and H.W. Querfurth Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes J. Biol. Chem. 279 2004 53524 53532
46. J. Cicenas, and M. Valius The CDK inhibitors in cancer research and therapy J. Cancer Res. Clin. Oncol. 137 2011 1409 1418
47. P.D. Coleman, and P.J. Yao Synaptic slaughter in Alzheimer's disease Neurobiol. Aging 24 2003 1023 1027
48. P.F. Copenhaver, T.S. Anekonda, D. Musashe, K.M. Robinson, J.M. Ramaker, T.L. Swanson, T.L. Wadsworth, D. Kretzschmar, R.L. Woltjer, and J.F. Quinn A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug Dis. Models Mech. 4 2011 634 648
49. A. Crowe, M.J. James, V.M. Lee, A.B. Smith III, J.Q. Trojanowski, C. Ballatore, and K.R. Brunden Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation J. Biol. Chem. 288 2013 11024 11037
50. H. Crystal, D. Dickson, P. Fuld, D. Masur, R. Scott, M. Mehler, J. Masdeu, C. Kawas, M. Aronson, and L. Wolfson Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease Neurology 38 1988 1682 1687
51. C. d'Abramo, C.M. Acker, H.T. Jimenez, and P. Davies Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity PloS One 8 2013 e62402
52. W. Danysz, C. Parsons, H.-J. MÖbius, A. StÖffler, and G. Quack Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - a unified glutamatergic hypothesis on the mechanism of action Neurotoxic. Res. 2 2000 85 97
53. D.G. Davis, F.A. Schmitt, D.R. Wekstein, and W.R. Markesbery Alzheimer neuropathologic alterations in aged cognitively normal subjects J. Neuropathol. Exp. Neurol. 58 1999 376 388
54. D. De Stefani, A. Raffaello, E. Teardo, I. Szabo, and R. Rizzuto A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter Nature 476 2011 336 340
55. B. De Strooper, P. Saftig, K. Craessaerts, H. Vanderstichele, G. Guhde, W. Annaert, K. Von Figura, and F. Van Leuven Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein Nature 391 1998 387 390
56. T. del Ser, K.C. Steinwachs, H.J. Gertz, M.V. Andres, B. Gomez-Carrillo, M. Medina, J.A. Vericat, P. Redondo, D. Fleet, and T. Leon Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study J. Alzheimer's Dis.: JAD 33 2013 205 215
57. R.B. DeMattos, K.R. Bales, D.J. Cummins, J.C. Dodart, S.M. Paul, and D.M. Holtzman Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 98 2001 8850 8855
58. 2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate J. Neurosci.: Off. J. Soc. Neurosci. 33 2013 3824 3833
59. A. Demuro, M. Smith, and I. Parker Single-channel Ca(2+) imaging implicates Abeta1-42 amyloid pores in Alzheimer's disease pathology J. Cell Biol. 195 2011 515 524
60. L.S. Deshpande, D.A. Sun, S. Sombati, A. Baranova, M.S. Wilson, E. Attkisson, R.J. Hamm, and R.J. DeLorenzo Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury Neurosci. Lett. 441 2008 115 119
61. D.W. Dodick, and J.J. Gargus Why migraines strike Sci. Am. 299 2008 56 63
62. Eli-Lilly, P.R., 2010. Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials.
63. Eli-Lilly, P.R., 2012. Eli Lilly and Company Announces Top-Line Results on Solanezumab Phase 3 Clinical Trials in Patients with Alzheimer's Disease.
64. Eli-Lilly, P.R., 2013. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor. Being Investigated as a Treatment for Alzheimer's Disease.
65. A. Extance Alzheimer's failure raises questions about disease-modifying strategies. Nature reviews Drug Discovery 9 2010 749 751
66. J.C. Fernandez-Morales, J.A. Arranz-Tagarro, E. Calvo-Gallardo, M. Maroto, J.F. Padin, and A.G. Garcia Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease ACS Chem. Neurosci. 3 2012 873 883
67. E. Finch, T. Turner, and S. Goldin Calcium as a coagonist of inositol 1,4,5-triphosphate-induced calcium release Science 252 1991 443 446
68. S.M. Fitzjohn, and G.L. Collingridge Calcium stores and synaptic plasticity Cell Calcium 32 2002 405 411
69. 2+ release channels in neurological diseases Pflugers Arch.: Eur. J. Physiol. 460 2010 481 494
70. D. Friel, and R. Tsien A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog sympathetic neurones modulates effects of Ca2+ entry on [Ca2+]i J. Physiol. 450 1992
71. S. Fujii, M. Matsumoto, K. Igarashi, H. Kato, and K. Mikoshiba Synaptic plasticity in hippocampal CA1 neurons of mice lacking type 1 inositol-1,4,5-trisphosphate receptors Learn. Mem. (Cold Spring Harbor, N.Y.) 7 2012 312 320
72. A. Futatsugi, K. Kato, H. Ogura, S.T. Li, E. Nagata, G. Kuwajima, K. Tanaka, S. Itohara, and K. Mikoshiba Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3 Neuron 24 1999 701 713
73. D. Galimberti, and E. Scarpini Disease-modifying treatments for Alzheimer's disease Ther. Adv. Neurol. Disord. 4 2011 203 216
74. J.J. Gargus Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism Ann. N. Y. Acad. Sci. 1151 2009 133 156
75. S.M. Gentleman, D.I. Graham, and G.W. Roberts Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease Prog. Brain Res. 96 1993 237 246
76. 2+ as a key regulator of cell life and death Cell Death Differ. 14 2007 1267 1274
77. S. Gilman, M. Koller, R.S. Black, L. Jenkins, S.G. Griffith, N.C. Fox, L. Eisner, L. Kirby, M.B. Rovira, F. Forette, and J.M. Orgogozo Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial Neurology 64 2005 1553 1562
78. A. Goate, and J. Hardy Twenty years of Alzheimer's disease-causing mutations J. Neurochem. 120 Suppl. 1 2012 3 8
79. M. Gold, C. Alderton, M. Zvartau-Hind, S. Egginton, A.M. Saunders, M. Irizarry, S. Craft, G. Landreth, U. Linnamagi, and S. Sawchak Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study Dementia Geriatr. Cognit. Disord. 30 2010 131 146
80. I. Goldenberg, and A.J. Moss Long QT syndrome J. Am. Coll. Cardiol. 51 2008 2291 2300
81. W.P. Goldman, J.L. Price, M. Storandt, E.A. Grant, D.W. McKeel Jr., E.H. Rubin, and J.C. Morris Absence of cognitive impairment or decline in preclinical Alzheimer's disease Neurology 56 2001 361 367
82. A. Gomez-Ramos, M. Diaz-Hernandez, R. Cuadros, F. Hernandez, and J. Avila Extracellular tau is toxic to neuronal cells FEBS Lett. 580 2006 4842 4850
83. A.M. Gomez, H.H. Valdivia, H. Cheng, M.R. Lederer, L.F. Santana, M.B. Cannell, S.A. McCune, R.A. Altschuld, and W.J. Lederer Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure Science (N. Y.) 276 1997 800 806
84. I. Goussakov, M.B. Miller, and G.E. Stutzmann NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice J. Neurosci.: Off. J. Soc. Neurosci. 30 2010 12128 12137
85. E.K. Green, D. Grozeva, I. Jones, L. Jones, G. Kirov, S. Caesar, K. Gordon-Smith, C. Fraser, L. Forty, E. Russell, M.L. Hamshere, V. Moskvina, I. Nikolov, A. Farmer, P. McGuffin, P.A. Holmans, M.J. Owen, M.C. O'Donovan, and N. Craddock The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia Mol. Psychiatry 15 2010 1016 1022
86. K.N. Green, H. Khashwji, T. Estrada, and F.M. Laferla ST101 induces a novel 17 kDa APP cleavage that precludes Abeta generation in vivo Ann. Neurol. 69 2011 831 844
87. R.C. Green, L.S. Schneider, D.A. Amato, A.P. Beelen, G. Wilcock, E.A. Swabb, and K.H. Zavitz Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial JAMA: J. Am. Med. Assoc. 302 2009 2557 2564
88. T. Gura Hope in Alzheimer's fight emerges from unexpected places Nat. Med. 14 2008 894
89. K.H. Gylys, J.A. Fein, F. Yang, D.J. Wiley, C.A. Miller, and G.M. Cole Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence Am. J. Pathol. 165 2004 1809 1817
90. A.M. Hagenston, J.S. Fitzpatrick, and M.F. Yeckel MGluR-mediated calcium waves that invade the soma regulate firing in layer V medial prefrontal cortical pyramidal neurons Cereb. Cortex 18 2008 407 423 (New York, N.Y.: 1991)
91. H. Hampel, M. Ewers, K. Burger, P. Annas, A. Mortberg, A. Bogstedt, L. Frolich, J. Schroder, P. Schonknecht, M.W. Riepe, I. Kraft, T. Gasser, T. Leyhe, H.J. Moller, A. Kurz, and H. Basun Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study J. Clin. Psychiatry 70 2009 922 931
92. 2+/calmodulin kinase II and protein kinase C in mouse hippocampus J. Pharmacol. Exp. Ther. 326 2008 127 134
93. D.P. Hanger, B.H. Anderton, and W. Noble Tau phosphorylation: the therapeutic challenge for neurodegenerative disease Trends Mol. Med. 15 2009 112 119
94. J. Hardy The amyloid hypothesis for Alzheimer's disease: a critical reappraisal J. Neurochem. 110 2009 1129 1134
95. J. Hardy, and D. Allsop Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol. Sci. 12 1991 383 388
96. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (New York, N.Y.)
97. C. Harrington, J.E. Rickard, D. Horsley, K.A. Harrington, K.P. Hindley, G. Riedel, F. Theuring, K.M. Seng, and C.M. Wischik 01-06-04: Methylthioninium chloride (MTC) acts as a Tau aggregation inhibitor (TAI) in a cellular model and reverses Tau pathology in transgenic mouse models of Alzheimer's disease Alzheimer's Dementia 4 2008 T120 T121
98. M. Hayley, S. Perspicace, T. Schulthess, and J. Seelig Calcium enhances the proteolytic activity of BACE1: An in vitro biophysical and biochemical characterization of the BACE1-calcium interaction Biochim. Biophy. Acta (BBA) - Biomembranes 1788 2009 1933 1938
99. L. Hedskog, C.M. Pinho, R. Filadi, A. Ronnback, L. Hertwig, B. Wiehager, P. Larssen, S. Gellhaar, A. Sandebring, M. Westerlund, C. Graff, B. Winblad, D. Galter, H. Behbahani, P. Pizzo, E. Glaser, and M. Ankarcrona Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models Proc. Natl. Acad. Sci. USA 110 2013 7916 7921
100. K. Herrup Reimagining Alzheimer's disease - an age-based hypothesis J. Neurosci.: Off. J. Soc. Neurosci. 30 2010 16755 16762
101. D.N. Hertle, and M.F. Yeckel Distribution of inositol-1,4,5-trisphosphate receptor isotypes and ryanodine receptor isotypes during maturation of the rat hippocampus Neuroscience 150 2007 625 638
102. C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins, A. Bayer, R.W. Jones, R. Bullock, S. Love, J.W. Neal, E. Zotova, and J.A. Nicoll Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial Lancet 372 2008 216 223
103. K. Honarnejad, C.K. Jung, S. Lammich, T. Arzberger, H. Kretzschmar, and J. Herms Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease J. Cell. Mol. Med. 17 2013 293 302
104. M. Hosokawa, T. Arai, M. Masuda-Suzukake, T. Nonaka, M. Yamashita, H. Akiyama, and M. Hasegawa Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice PloS One 7 2012 e52389
105. N.W. Hu, T. Ondrejcak, and M.J. Rowan Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances Pharmacol., Biochem., Behav. 100 2012 855 862
106. X. Hu, C.W. Hicks, W. He, P. Wong, W.B. Macklin, B.D. Trapp, and R. Yan Bace1 modulates myelination in the central and peripheral nervous system Nat. Neurosci. 9 2006 1520 1525
107. D.E. Iles, F. Lehmann-Horn, S.W. Scherer, L.C. Tsui, D. Olde Weghuis, R.F. Suijkerbuijk, L. Heytens, G. Mikala, A. Schwartz, and F.R. Ellis Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families Hum. Mol. Genet. 3 1994 969 975
108. E. Ilijic, J.N. Guzman, and D.J. Surmeier The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease Neurobiol. Dis. 43 2011 364 371
109. B.P. Imbimbo Why did tarenflurbil fail in Alzheimer's disease? J. Alzheimer's Dis.: JAD 17 2009 757 760
110. B.P. Imbimbo, L. Giardino, S. Sivilia, A. Giuliani, M. Gusciglio, V. Pietrini, E. Del Giudice, A. D'Arrigo, A. Leon, G. Villetti, and L. Calza CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease J. Alzheimer's Dis.: JAD 20 2010 159 173
111. P. Imbrici, D.C. Camerino, and D. Tricarico Major channels involved in neuropsychiatric disorders and therapeutic perspectives Front. Genet. 4 2013 76
112. K. Iqbal, C. Alonso Adel, S. Chen, M.O. Chohan, E. El-Akkad, C.X. Gong, S. Khatoon, B. Li, F. Liu, A. Rahman, H. Tanimukai, and I. Grundke-Iqbal Tau pathology in Alzheimer disease and other tauopathies Biochim. Biophys. Acta 1739 2005 198 210
113. J.H. Jaggar, V.A. Porter, W.J. Lederer, and M.T. Nelson Calcium sparks in smooth muscle Am. J. Physiol.: Cell Physiol. 278 2000 C235 C256
114. J.W. Johnson, and S.E. Kotermanski Mechanism of action of memantine Curr. Opinion Pharmacol. 6 2006 61 67
115. V.E. Johnson, W. Stewart, and D.H. Smith Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease? Nat. Rev. Neurosci. 11 2010 361 370
116. K. Jurkat-Rott, F. Lehmann-Horn, A. Elbaz, R. Heine, R.G. Gregg, K. Hogan, P.A. Powers, P. Lapie, J.E. Vale-Santos, and J. Weissenbach A calcium channel mutation causing hypokalemic periodic paralysis Hum. Mol. Genet. 3 1994 1415 1419
117. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discovery 10 2011 698 712
118. A.M. Kazee, and E.M. Johnson Alzheimer's disease pathology in non-demented elderly J. Alzheimer's Dis.: JAD 1 1998 81 89
119. S.P. Kennelly, L. Abdullah, D. Paris, J. Parish, V. Mathura, M. Mullan, F. Crawford, B.A. Lawlor, and R.A. Kenny Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug nilvadipine: results from a 6-week open label study Int. J. Geriatr. Psychiatry 26 2011 1038 1045
120. J.S. Kim, L. He, and J.J. Lemasters Mitochondrial permeability transition: a common pathway to necrosis and apoptosis Biochem. Biophys. Res. Commun. 304 2003 463 470
121. W.E. Klunk, J.C. Price, C.A. Mathis, N.D. Tsopelas, B.J. Lopresti, S.K. Ziolko, W. Bi, J.A. Hoge, A.D. Cohen, M.D. Ikonomovic, J.A. Saxton, B.E. Snitz, D.A. Pollen, M. Moonis, C.F. Lippa, J.M. Swearer, K.A. Johnson, D.M. Rentz, A.J. Fischman, H.J. Aizenstein, and S.T. DeKosky Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J. Neurosci.: Off. J. Soc. Neurosci. 27 2007 6174 6184
122. R. Kopan, and M.X. Ilagan The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 2009 216 233
123. P.L. Kramer, H. Xu, R.L. Woltjer, S.K. Westaway, D. Clark, D. Erten-Lyons, J.A. Kaye, K.A. Welsh-Bohmer, J.C. Troncoso, W.R. Markesbery, R.C. Petersen, R.S. Turner, W.A. Kukull, D.A. Bennett, D. Galasko, J.C. Morris, and J. Ott Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study Neurobiol. Aging 32 2011 2113 2122
124. D.M. Kullmann Neurological channelopathies Annu. Rev. Neurosci. 33 2010 151 172
125. F.M. LaFerla Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease Nat. Rev. Neurosci. 3 2002 862 872
126. G. Landreth, Q. Jiang, S. Mandrekar, and M. Heneka PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease Neurother.: J. Am. Soc. Exp. NeuroTher. 5 2008 481 489
127. M. Leist, B. Single, A.F. Castoldi, S. Kuhnle, and P. Nicotera Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis J. Exp. Med. 185 1997 1481 1486
128. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W.L. Lin, S.H. Yen, D.W. Dickson, P. Davies, and M. Hutton Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat. Genet. 25 2000 402 405
129. X. Liu, J. Betzenhauser Matthew, S. Reiken, C. Meli Albano, W. Xie, B-X. Chen, O. Arancio, and R. Marks Andrew Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction Cell 150 2012 1055 1067
130. A.T. Lu, X. Dai, J.A. Martinez-Agosto, and R.M. Cantor Support for calcium channel gene defects in autism spectrum disorders Mol. Autism 3 2012 18
131. X. Luo, and R. Yan Inhibition of BACE1 for therapeutic use in Alzheimer's disease Int. J. Clin. Exp. Pathol. 3 2010 618 628
132. C.L. Maarouf, I.D. Daugs, T.A. Kokjohn, D.G. Walker, J.M. Hunter, J.C. Kruchowsky, R. Woltjer, J. Kaye, E.M. Castano, M.N. Sabbagh, T.G. Beach, and A.E. Roher Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging PloS One 6 2011 e27291
133. A. Maelicke, M. Samochocki, R. Jostock, A. Fehrenbacher, J. Ludwig, E.X. Albuquerque, and M. Zerlin Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease Biol. Psychiatry 49 2001 279 288
134. R.C. Malenka, and M.F. Bear LTP and LTD: an embarrassment of riches Neuron 44 2004 5 21
135. R.C. Malenka, and R.A. Nicoll Long-term potentiation - a decade of progress? Science 285 1999 1870 1874 (New York, N.Y.)
136. J.D. Malhotra, and R.J. Kaufman ER stress and its functional link to mitochondria: role in cell survival and death Cold Spring Harbor Perspect. Biol. 3 2011 a004424
137. 2+ uptake that regulates cellular metabolism Nat. Cell Biol. 14 2012 1336 1343
138. K. Mallilankaraman, P. Doonan, C. Cardenas, H.C. Chandramoorthy, M. Muller, R. Miller, N.E. Hoffman, R.K. Gandhirajan, J. Molgo, M.J. Birnbaum, B.S. Rothberg, D.O. Mak, J.K. Foskett, and M. Madesh MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival Cell 151 2012 630 644
139. S.J. Martin, P.D. Grimwood, and R.G.M. Morris Synaptic plasticity and memory: an evaluation of the hypothesis Annu. Rev. Neurosci. 23 2000 649 711
140. F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto Alzheimer's disease: clinical trials and drug development Lancet Neurol. 9 2010 702 716
141. R. Medeiros, D. Baglietto-Vargas, and F.M. LaFerla The role of tau in Alzheimer's disease and related disorders CNS Neurosci. Ther. 17 2011 514 524
142. L. Mei, and W.C. Xiong Neuregulin 1 in neural development, synaptic plasticity and schizophrenia Nat. Rev. Neurosci. 9 2008 437 452
143. B. Mellstrom, and J.R. Naranjo Mechanisms of Ca(2+)-dependent transcription Curr. Opinion Neurobiol. 11 2001 312 319
144. G.V. Michailov, M.W. Sereda, B.G. Brinkmann, T.M. Fischer, B. Haug, C. Birchmeier, L. Role, C. Lai, M.H. Schwab, and K.A. Nave Axonal neuregulin-1 regulates myelin sheath thickness Science 304 2004 700 703 (New York, N.Y.)
145. N. Monnier, V. Procaccio, P. Stieglitz, and J. Lunardi Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle Am. J. Hum. Genet. 60 1997 1316 1325
146. 2+ concentration Curr. Biol.: CB 16 2006 1672 1677
147. S. Moriguchi, N. Shioda, Y. Yamamoto, H. Tagashira, and K. Fukunaga The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of long-term potentiation and CaMKII autophosphorylation in rat cortical slices J. Neurochem. 121 2012 44 53
148. J.H. Morrison, and P.R. Hof Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease Prog. Brain Res. 136 2002 467 486
149. R.M. Mulkey, and R.C. Malenka Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus Neuron 9 1992 967 975
150. K. Mullane, and M. Williams Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? Biochem. Pharmacol. 85 2013 289 305
151. 2+ signaling Proc. Natl. Acad. Sci. USA 108 2011 13293 13298
152. K.A. Nave, and J.L. Salzer Axonal regulation of myelination by neuregulin 1 Curr. Opinion Neurobiol. 16 2006 492 500
153. O. Nelson, C. Supnet, A. Tolia, K. Horre, B. De Strooper, and I. Bezprozvanny Mutagenesis mapping of the presenilin 1 calcium leak conductance pore J. Biol. Chem. 286 2011 22339 22347
154. 2+ leak function of presenilin 1 J. Clin. Invest. 117 2007 1230 1239
155. J.A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat. Med. 9 2003 448 452
156. S. Nizami, V.W. Lee, J. Davies, P. Long, J.N. Jovanovic, and T.S. Sihra Presynaptic roles of intracellular Ca(2+) stores in signalling and exocytosis Biochem. Soc. Trans. 38 2010 529 535
157. A. Nordberg Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease Alzheimer disease and associated disorders 20 2006 S12 S18
158. N. Ohkubo, N. Mitsuda, M. Tamatani, A. Yamaguchi, Y.D. Lee, T. Ogihara, M.P. Vitek, and M. Tohyama Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway J. Biol. Chem. 276 2001 3046 3053
159. 2+ channel gene CACNL1A4 Cell 87 1996 543 552
160. J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, L.C. Kirby, P. Jouanny, B. Dubois, L. Eisner, S. Flitman, B.F. Michel, M. Boada, A. Frank, and C. Hock Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization Neurology 61 2003 46 54
161. S. Orrenius, D.H. Burgess, M.B. Hampton, and B. Zhivotovsky Mitochondria as the focus of apoptosis research Cell Death Differ. 4 1997 427 428
162. 2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia J. Biol. Chem. 269 1994 9413 9415
163. B. Oules, D. Del Prete, B. Greco, X. Zhang, I. Lauritzen, J. Sevalle, S. Moreno, P. Paterlini-Brechot, M. Trebak, F. Checler, F. Benfenati, and M. Chami Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease J. Neurosci.: Off. J. Soc. Neurosci. 32 2012 11820 11834
164. J.J. Palop, and L. Mucke Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromol. Med. 12 2010 48 55
165. 2+ exchange Proc. Natl. Acad. Sci. USA 107 2010 436 441
166. 2+ influx mechanisms Sci. China Life Sci. 54 2011 763 769
167. C.S. Park, Y. Elgersma, S.G. Grant, and J.H. Morrison Alpha-isoform of calcium-calmodulin-dependent protein kinase II and postsynaptic density protein 95 differentially regulate synaptic expression of NR2A- and NR2B-containing N-methyl-d-aspartate receptors in hippocampus Neuroscience 151 2008 43 55
168. A.J. Payne, B.C. Gerdes, Y. Naumchuk, A.E. McCalley, S. Kaja, and P. Koulen Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines Exp. Neurol. 2013
169. J.J. Pei, M. Sjogren, and B. Winblad Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets Curr. Opinion Psychiatry 21 2008 555 561
170. J. Peng, G. Liang, S. Inan, Z. Wu, D.J. Joseph, Q. Meng, Y. Peng, M.F. Eckenhoff, and H. Wei Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice Neurosci. Lett. 516 2012 274 279
171. Pfizer, P.R., 2012. Co-Primary Clinical Endpoints Not Met In Second Phase 3 Bapineuzumab Study In Mild-To-Moderate Alzheimer's Disease Patients Who Do Not Carry The Apoe4 Genotype.
172. D. Pietrobon CaV2.1 channelopathies Pflugers Arch.: Eur. J. Physiol. 460 2010 375 393
173. S.W. Pimplikar, R.A. Nixon, N.K. Robakis, J. Shen, and L.H. Tsai Amyloid-independent mechanisms in Alzheimer's disease pathogenesis J. Neurosci.: Off. J. Soc. Neurosci. 30 2010 14946 14954
174. E. Popugaeva, and I. Bezprozvanny Role of endoplasmic reticulum calcium signaling in the pathogenesis of Alzheimer disease Front. Mol. Neurosci. 6 2013 1 7
175. K.G. Pratt, E.C. Zimmerman, D.G. Cook, and J.M. Sullivan Presenilin 1 regulates homeostatic synaptic scaling through Akt signaling Nat. Neurosci. 14 2011 1112 1114
176. J.L. Price, D.W. McKeel Jr., V.D. Buckles, C.M. Roe, C. Xiong, M. Grundman, L.A. Hansen, R.C. Petersen, J.E. Parisi, D.W. Dickson, C.D. Smith, D.G. Davis, F.A. Schmitt, W.R. Markesbery, J. Kaye, R. Kurlan, C. Hulette, B.F. Kurland, R. Higdon, W. Kukull, and J.C. Morris Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease Neurobiol. Aging 30 2009 1026 1036
177. S.G. Priori, and C. Napolitano Role of genetic analyses in cardiology. Part I: mendelian diseases: cardiac channelopathies Circulation 113 2006 1130 1135
178. L.J. Ptacek, R. Tawil, R.C. Griggs, A.G. Engel, R.B. Layzer, H. Kwiecinski, P.G. McManis, L. Santiago, M. Moore, and G. Fouad Dihydropyridine receptor mutations cause hypokalemic periodic paralysis Cell 77 1994 863 868
179. M.S. Rafii, and P.S. Aisen Recent developments in Alzheimer's disease therapeutics BMC Med. 7 2009 7
180. S. Rajakulendran, D. Kaski, and M.G. Hanna Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS Nat. Rev. Neurol. 8 2012 86 96
181. 2+) transfer from the ER to mitochondria: when, how and why Biochim. Biophys. Acta 1787 2009 1342 1351
182. N.K. Robakis Mechanisms of AD neurodegeneration may be independent of Abeta and its derivatives Neurobiol. Aging 32 2011 372 379
183. R. Romaniello, C. Zucca, A. Tonelli, S. Bonato, C. Baschirotto, N. Zanotta, R. Epifanio, A. Righini, N. Bresolin, M.T. Bassi, and R. Borgatti A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation J. Neurol., Neurosurg., Psychiatry 81 2010 840 843
184. Roskamp-Institute, P.R., 2012. Key Clinical Trial Of Alzheimer's Disease Drug Begins In Europe.
185. V. Rybalchenko, S.Y. Hwang, N. Rybalchenko, and P. Koulen The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity Int. J. Biochem. Cell Biol. 40 2008 84 97
186. A.V. Savonenko, T. Melnikova, F.M. Laird, K.A. Stewart, D.L. Price, and P.C. Wong Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice Proc. Natl. Acad. Sci. USA 105 2008 5585 5590
187. A.H. Schapira Calcium dysregulation in Parkinson's disease Brain: J. Neurol. 136 2013 2015 2016
188. S.W. Scheff, and D.A. Price Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies Neurobiol. Aging 24 2003 1029 1046
189. D. Schenk, M. Hagen, and P. Seubert Current progress in beta-amyloid immunotherapy Curr. Opinion Immunol. 16 2004 599 606
190. F.A. Schmitt, D.G. Davis, D.R. Wekstein, C.D. Smith, J.W. Ashford, and W.R. Markesbery "Preclinical" AD revisited: neuropathology of cognitively normal older adults Neurology 55 2000 370 376
191. L.S. Schneider, K.S. Dagerman, J.P. Higgins, and R. McShane Lack of evidence for the efficacy of memantine in mild Alzheimer disease Arch. Neurol. 68 2011 991 998
192. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
193. D.J. Selkoe Resolving controversies on the path to Alzheimer's therapeutics Nat. Med. 17 2011 1060 1065
194. A. Serrano-Pozo, C.M. William, I. Ferrer, E. Uro-Coste, M.B. Delisle, C.A. Maurage, C. Hock, R.M. Nitsch, E. Masliah, J.H. Growdon, M.P. Frosch, and B.T. Hyman Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology Brain: J. Neurol. 133 2010 1312 1327
195. 2+ leak channels J. Biol. Chem. 287 2012 10933 10944
196. 2+ signaling by axonal ryanodine receptors at the hippocampal mossy fiber synapse Proc. Natl. Acad. Sci. USA 105 2008 11998 12003
197. N. Shioda, Y. Yamamoto, F. Han, S. Moriguchi, Y. Yamaguchi, M. Hino, and K. Fukunaga A novel cognitive enhancer, ZSET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice J. Pharmacol. Exp. Ther. 333 2010 43 50
198. S. Shively, A.I. Scher, D.P. Perl, and R. Diaz-Arrastia Dementia resulting from traumatic brain injury: what is the pathology? Arch. Neurol. 69 2012 1245 1251
199. G.C. Shore, F.R. Papa, and S.A. Oakes Signaling cell death from the endoplasmic reticulum stress response Curr. Opinion Cell Biol. 23 2011 143 149
200. S. Sivanesan, A. Tan, and J. Rajadas Pathogenesis of Abeta oligomers in synaptic failure Curr. Alzheimer Res. 10 2013 316 323
201. D.H. Small, R. Gasperini, A.J. Vincent, A.C. Hung, and L. Foa The Role of Aβ-induced calcium dysregulation in the pathogenesis of Alzheimer's disease J. Alzheimer's Dis. 16 2009 225 233
202. I. Splawski, K.W. Timothy, L.M. Sharpe, N. Decher, P. Kumar, R. Bloise, C. Napolitano, P.J. Schwartz, R.M. Joseph, K. Condouris, H. Tager-Flusberg, S.G. Priori, M.C. Sanguinetti, and M.T. Keating Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
203. O.K. Steinlein Genetics and epilepsy Dialogues Clin. Neurosci. 10 2008 29 38
204. G.E. Stutzmann The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"? Neurosci.: Rev. J. Bringing Neurobiol., Neurol. Psychiatry 13 2007 546 559
205. 2+ disruptions in young, adult, and aged Alzheimer's disease mice J. Neurosci.: Off. J. Soc. Neurosci. 26 2006 5180 5189
206. G.E. Stutzmann, I. Smith, A. Caccamo, S. Oddo, I. Parker, and F. Laferla Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models Ann. N. Y. Acad. Sci. 1097 2007 265 277
207. C. Supnet, J. Grant, H. Kong, D. Westaway, and M. Mayne Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice J. Biol. Chem. 281 2006 38440 38447
208. C. Supnet, C. Noonan, K. Richard, J. Bradley, and M. Mayne Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer's disease J. Neurochem. 112 2010 356 365
209. 2+ signaling Biochim. Biophys. Acta 1763 2006 442 449
210. I. Tabas, and D. Ron Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress Nat. Cell Biol. 13 2011 184 190
211. J.J.N. Tang Beta-secretase as target for amyloid-reduction therapy Alzheimer's Dementia: J. Alzheimer's Assoc. 5 2009 P74
212. P.N. Tariot, and P.S. Aisen Can lithium or valproate untie tangles in Alzheimer's disease? J. Clin. Psychiatry 70 2009 919 921
213. M. Tesli, K.C. Skatun, O.T. Ousdal, A.A. Brown, C. Thoresen, I. Agartz, I. Melle, S. Djurovic, J. Jensen, and O.A. Andreassen CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls PloS One 8 2013 e56970
214. The-International-Schizophrenia-Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 460 2009 748 752
215. M. Tolar, J.N. Keller, S. Chan, M.P. Mattson, M.A. Marques, and K.A. Crutcher Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity J. Neurosci.: Off. J. Soc. Neurosci. 19 1999 7100 7110
216. L. Troquier, R. Caillierez, S. Burnouf, F.J. Fernandez-Gomez, M.E. Grosjean, N. Zommer, N. Sergeant, S. Schraen-Maschke, D. Blum, and L. Buee Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach Curr. Alzheimer Res. 9 2012 397 405
217. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations Cell 126 2006 981 993
218. J.W. Um, A.C. Kaufman, M. Kostylev, J.K. Heiss, M. Stagi, H. Takahashi, M.E. Kerrisk, A. Vortmeyer, T. Wisniewski, A.J. Koleske, E.C. Gunther, H.B. Nygaard, and S.M. Strittmatter Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein Neuron 79 2013 887 902
219. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, and M. Citron Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741 (New York, N.Y.)
220. A. Verkhratsky The endoplasmic reticulum and neuronal calcium signalling Cell Calcium 32 2002 393 404
221. J. Wang, K. Ono, D.L. Dickstein, I. Arrieta-Cruz, W. Zhao, X. Qian, A. Lamparello, R. Subnani, M. Ferruzzi, C. Pavlides, L. Ho, P.R. Hof, D.B. Teplow, and G.M. Pasinetti Carvedilol as a potential novel agent for the treatment of Alzheimer's disease Neurobiol. Aging 32 2011 (2321 e2321-2312)
222. S. Watanabe, M. Hong, N. Lasser-Ross, and W.N. Ross Modulation of calcium wave propagation in the dendrites and to the soma of rat hippocampal pyramidal neurons J. Physiol. 575 2006 455 468
223. J.T. Weber Calcium homeostasis following traumatic neuronal injury Curr. Neurovasc. Res. 1 2004 151 171
224. J.T. Weber Altered calcium signaling following traumatic brain injury Front. Pharmacol. 3 2012 60
225. M. Willem, A.N. Garratt, B. Novak, M. Citron, S. Kaufmann, A. Rittger, B. DeStrooper, P. Saftig, C. Birchmeier, and C. Haass Control of peripheral nerve myelination by the beta-secretase BACE1 Science 314 2006 664 666 (New York, N.Y.)
226. A. Wimo, L. Jönsson, J. Bond, M. Prince, and B. Winblad The worldwide economic impact of dementia 2010 Alzheimer's Dementia: J. Alzheimer's Assoc. 9 2013 1-11.e13
227. J.R. Whitlock, A.J. Heynen, M.G. Shuler, and M.F. Bear Learning induces long-term potentiation in the hippocampus Science 313 2006 1093 1097
228. B. Wu, H. Yamaguchi, F.A. Lai, and J. Shen Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons Proc. Natl. Acad. Sci. USA 110 2013 15091 15096
229. H.M. Wu, N.S. Tzeng, L. Qian, S.J. Wei, X. Hu, S.H. Chen, S.M. Rawls, P. Flood, J.S. Hong, and R.B. Lu Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 34 2009 2344 2357
230. J. Wu, H.P. Shih, V. Vigont, L. Hrdlicka, L. Diggins, C. Singh, M. Mahoney, R. Chesworth, G. Shapiro, O. Zimina, X. Chen, Q. Wu, L. Glushankova, M. Ahlijanian, G. Koenig, G.N. Mozhayeva, E. Kaznacheyeva, and I. Bezprozvanny Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment Chem. Biol. 18 2011 777 793
231. Y. Yamaguchi, H. Miyashita, H. Tsunekawa, A. Mouri, H.C. Kim, K. Saito, T. Matsuno, S. Kawashima, and T. Nabeshima Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat J. Pharmacol. Exp. Ther. 317 2006 1079 1087
232. Y. Yamamoto, N. Shioda, F. Han, S. Moriguchi, and K. Fukunaga Novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltage-gated calcium channel stimulation J. Pharmacol. Sci. 121 2013 212 226
233. 2+ channels reduces alzheimer disease beta-amyloid peptide secretion J. Biol. Chem. 288 2013 26955 26966
234. C. Zhang, B. Wu, V. Beglopoulos, M. Wines-Samuelson, D. Zhang, I. Dragatsis, T.C. Sudhof, and J. Shen Presenilins are essential for regulating neurotransmitter release Nature 460 2009 632 636
235. D. Zhang, C. Zhang, A. Ho, A. Kirkwood, T.C. Sudhof, and J. Shen Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction J. Neurochem. 115 2010 1215 1221
236. H. Zhang, S. Sun, A. Herreman, B. De Strooper, and I. Bezprozvanny Role of presenilins in neuronal calcium homeostasis J. Neurosci.: Off. J. Soc. Neurosci. 30 2010 8566 8580